Sign Up Today and Learn More About QurAlis Stock
Invest in or calculate the value of your shares in QurAlis or other pre-IPO companies through EquityZen's platform.
QurAlis Stock (QURL)
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
About QurAlis Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
QurAlis Press Mentions
Stay in the know about the latest news on QurAlis
QurAlis Doses First Patient With ALS in Phase 1 Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS
prnewswire • Dec 04, 2024
QurAlis to Participate at the Piper Sandler 36th Annual Healthcare Conference
prnewswire • Nov 25, 2024
QurAlis' ANQUR Clinical Trial of QRL-201 in ALS Advances to Dose Range-Finding (DRF) Phase With First Participant Dosed
prnewswire • Nov 19, 2024
QurAlis to Participate in Upcoming Investor and Industry Conferences in September
prnewswire • Aug 21, 2024
QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors
prnewswire • Aug 04, 2024
QurAlis Management
Leadership team at QurAlis
Board Observer
Anthony Walsh
Board of Directors
Cillian King
Join now and verify your accreditation status to gain access to:
- QurAlis current valuation
- QurAlis stock price
- Available deals in QurAlis and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading QurAlis Stock
How to invest in QurAlis stock?
Accredited investors can buy pre-IPO stock in companies like QurAlis through EquityZen funds. These investments are made available by existing QurAlis shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell QurAlis stock?
Shareholders can sell their QurAlis stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
